Madrigal Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference Feb 24, 2026 08:00AM
Madrigal Pharmaceuticals (MDGL) PT Raised at TD Cowen on EU approval of Rezdiffra Aug 26, 2025 08:38AM
TD Cowen Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL), PT $390 Feb 26, 2025 03:55PM
Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference Feb 21, 2025 08:00AM
TD Cowen Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL) Nov 20, 2024 07:46AM


Mar 19, 2024 12:02AM Madrigal Pharma (MDGL) Announces Pricing of Upsized $600 Million Public Offering
Mar 18, 2024 11:58PM Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering
Mar 18, 2024 04:04PM Madrigal Pharma (MDGL) Announces Proposed $500M Public Offering
Mar 18, 2024 04:04PM Madrigal Pharmaceuticals Announces Proposed Public Offering
Mar 15, 2024 06:54AM Madrigal Pharmaceuticals (MDGL) PT Raised to $390 at TD Cowen
Sep 29, 2023 05:38AM Madrigal Pharma (MDGL) Prices $500M Share and Warrant Offering at $151/sh
Sep 28, 2023 10:30PM Madrigal Pharmaceuticals Announces Pricing of $500 Million Public Offering
Sep 28, 2023 04:01PM Madrigal Pharma (MDGL) Announces Proposed $500M Share Offering
Sep 28, 2023 04:01PM Madrigal Pharmaceuticals Announces Proposed Public Offering
Feb 8, 2023 08:00AM Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
Dec 19, 2022 03:52PM Madrigal Pharmaceuticals (MDGL) PT Raised to $309 at Cowen, 'Safety Remains Clean', 'We are very encouraged by today's data'
Jun 23, 2022 06:46AM Madrigal Pharmaceuticals (MDGL) Named Best SMIDCap Idea at Cowen
Jun 7, 2018 05:49AM Madrigal Pharma (MDGL) Announces 1.347 Million Shares of Common Stock Offering Price at $305/Share
Jun 6, 2018 11:14PM Madrigal Pharmaceuticals Prices Public Offering of Common Stock
Jun 6, 2018 11:14PM Madrigal Pharmaceuticals Prices Public Offering of Common Stock
Feb 28, 2018 05:42AM Cowen Starts Madrigal Pharmaceuticals (MDGL) at Outperform